Pinnacle Wealth Planning Services
MDGL icon

Pinnacle Wealth Planning Services’s Madrigal Pharmaceuticals MDGL Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$106K Sell
210
-13
-6% -$6.87K 0.01% 828
2026
Q2 		$120K Sell
223
-9
-4% -$4.61K 0.01% 773
2026
Q1 		$121K Sell
232
-1
-0.4% -$478 0.01% 700
2025
Q4 		$136K Buy
+233
New +$119K 0.01% 628

Other funds holding MDGL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
EULAV Asset Management
EULAV Asset Management Sarasota, Florida $2.77B AUM 18.47% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Pinnacle Wealth Planning Services's MDGL Position: Q3 2026 in Review

Pinnacle Wealth Planning Services reduced its Madrigal Pharmaceuticals (MDGL) stake by 5.8% in Q3 2026, selling an estimated $6.87K and leaving 210 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #828.

Pinnacle Wealth Planning Services first reported a position in MDGL in Q4 2025 and has held it in 4 quarters since. The position peaked at $136K in Q4 2025. 180 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • Pinnacle Wealth Planning Services held 210 shares of Madrigal Pharmaceuticals worth $106K as of Q3 2026.
  • Pinnacle Wealth Planning Services sold 13 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $6.87K.
  • Madrigal Pharmaceuticals made up 0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #828 holding.
  • Pinnacle Wealth Planning Services first reported a position in Madrigal Pharmaceuticals in Q4 2025 and has held it in 4 quarters since.
  • Pinnacle Wealth Planning Services's Madrigal Pharmaceuticals position peaked at $136K in Q4 2025.
  • 180 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.